CLINICAL_TRIALS
trial_result
· 2018-06-14
Clinical Trial Update: The Peregrine Study: A Safety and Performance Study of Renal Denervation [NA]
Summary
The Peregrine Study, conducted by Ablative Solutions, Inc., completed its safety and performance evaluation of a renal denervation system for hypertension.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ablative Solutions, Inc. | Conditions: Hypertension | NA | Status: COMPLETED